Zhendong Pharmaceutical announced that the new drug application for the core product “Lactobacillus conjugated probiotic capsules for vaginal use” of Guangdong Longchuangji Pharmaceutical Co., Ltd., in which the company is a shareholder, has been accepted by the Drug Evaluation Center of the China National Drug Administration. This drug is a compound preparation. The main ingredients are active bacteria Lactobacillus grifolia and Lactobacillus rhamnosus. It is used for the restoration of vaginal flora and the treatment of bacterial vaginosis.

Zhendong Pharmaceutical announced that the new drug application for the core product “Lactobacillus conjugated probiotic capsules for vaginal use” of Guangdong Longchuangji Pharmaceutical Co., Ltd., in which the company is a shareholder, has been accepted by the Drug Evaluation Center of the China National Drug Administration. This drug is a compound preparation. The main ingredients are active bacteria Lactobacillus grifolia and Lactobacillus rhamnosus. It is used for the restoration of vaginal flora and the treatment of bacterial vaginosis.